In the original version of this article (1), author Charleen T. Chu is mistakenly omitted from the author list. This error has been corrected in the latest online HTML and PDF versions of the article and the author contributions and disclosures have been updated as necessary. A citation to ref. 2 (below) has also been added to the Introduction after the sentence “Moreover, constitutively activated ERK drives increased autophagy and lysosomal content” and to the “Plasmids and Other Regents” section of the Methods after the sentence “The engineered kinase-deficient GFP-ERK2(K52R)-KD plasmid was constructed in the pEGFP-C1 mammalian expression backbone.” The references have been updated in the latest online HTML and PDF versions of the article. The authors regret these errors.
Skip Nav Destination
Article navigation
1 July 2019
Corrections|
July 01 2019
Correction: ER Translocation of the MAPK Pathway Drives Therapy Resistance in BRAF-Mutant Melanoma
Online ISSN: 2159-8290
Print ISSN: 2159-8274
©2019 American Association for Cancer Research.
2019
American Association for Cancer Research.
Cancer Discov (2019) 9 (7): 981.
Related Content
This is a correction to:
ER Translocation of the MAPK Pathway Drives Therapy Resistance in BRAF-Mutant Melanoma
Citation
Correction: ER Translocation of the MAPK Pathway Drives Therapy Resistance in BRAF-Mutant Melanoma. Cancer Discov 1 July 2019; 9 (7): 981. https://doi.org/10.1158/2159-8290.CD-19-0632
Download citation file:
285
Views
Citing articles via
Advertisement